Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | Integrin beta-3 precursor, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Loa Loa (eye worm) | integrin beta-2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma japonicum | ko:K06464 integrin beta 2, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma mansoni | integrin beta subunit | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma japonicum | Integrin beta-PS precursor, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Echinococcus granulosus | integrin beta 2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Brugia malayi | Integrin beta pat-3 precursor | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Echinococcus multilocularis | integrin beta 2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0189 | 0.3553 | 0.592 |
Leishmania major | CAAX prenyl protease 2, putative,peptidase with unknown catalytic mechanism (family U48) | 0.0189 | 0.3553 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0189 | 0.3553 | 0.3553 |
Trypanosoma cruzi | CAAX prenyl protease 2, putative | 0.0189 | 0.3553 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0128 | 0.1985 | 0.1985 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0128 | 0.1985 | 0.1985 |
Trichomonas vaginalis | Clan U, family U48, CaaX prenyl peptidase 2-like | 0.0189 | 0.3553 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.1182 | 0.1182 |
Echinococcus multilocularis | integrin beta 2 | 0.0322 | 0.6966 | 1 |
Entamoeba histolytica | CAAX prenyl protease family | 0.0189 | 0.3553 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.0253 | 0.5188 | 1 |
Brugia malayi | CAAX amino terminal protease family protein | 0.0189 | 0.3553 | 0.3553 |
Loa Loa (eye worm) | integrin beta-2 | 0.0439 | 1 | 1 |
Echinococcus granulosus | integrin beta 2 | 0.0322 | 0.6966 | 1 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0069 | 0.0451 | 0.0451 |
Onchocerca volvulus | 0.0097 | 0.1182 | 1 | |
Brugia malayi | Trypsin family protein | 0.0097 | 0.1182 | 0.1182 |
Brugia malayi | MH2 domain containing protein | 0.0128 | 0.1985 | 0.1985 |
Trypanosoma brucei | CAAX amino terminal protease, putative | 0.0189 | 0.3553 | 0.5 |
Brugia malayi | hypothetical protein | 0.0069 | 0.0451 | 0.0451 |
Giardia lamblia | Hypothetical protein | 0.0189 | 0.3553 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.0451 | 0.0451 |
Trypanosoma cruzi | peptidase with unknown catalytic mechanism (family U48) | 0.0189 | 0.3553 | 0.5 |
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0189 | 0.3553 | 0.592 |
Brugia malayi | Kelch motif family protein | 0.0069 | 0.0451 | 0.0451 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.1182 | 0.1182 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (binding) | = 0.11 uM | Dissociation constant for human Lymphocyte function associated antigen 1 in LFA-1/ICAM-1 binding assay | ChEMBL. | 15481974 |
Kd (binding) | = 0.11 uM | Dissociation constant for human Lymphocyte function associated antigen 1 in LFA-1/ICAM-1 binding assay | ChEMBL. | 15481974 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.